Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
F1000Prime Reports|November 7, 2014
Advances in treating acute myeloid leukemiaMargaret M Showel, Mark Levis
Case Reports in Oncology|April 8, 2015
Tyrosine kinase inhibitor induced isolated pericardial effusionVineet Agrawal, Eric S Christenson, Margaret M Showel
Current Opinion in Hematology|December 18, 2004
Recent advances in the development of small-molecule inhibitors for the treatment of acute myeloid leukemiaMark Levis
Blood|May 27, 2017
Midostaurin approved for FLT3-mutated AMLMark Levis
Hematology. American Society of Hematology. Education Program|December 10, 2013
FLT3 mutations in acute myeloid leukemia: what is the best approach in 2013?Mark Levis
The Journal of Experimental Medicine|June 23, 2017
FLT3 dancing on the stem cellMark Levis
Blood|May 19, 2011
FLT3/ITD AML and the law of unintended consequencesMark Levis
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2012
Phospho-specific flow: fixating on the targetMark Levis
Hematology. American Society of Hematology. Education Program|December 5, 2025
Post-HCT maintenance therapy for AML: who, when, why, how long?Mark Levis
Best Practice & Research. Clinical Haematology|March 25, 2021
Is there evidence for the use of FLT3 inhibitors as maintenance therapy in AML?Mark Levis
Pageof 11